| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.56 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |